Document is current
Any future updates will be listed below
-
Authors
Villacis-Nunez, D. Sofia https://orcid.org/0000-0001-9182-6067
Rostad, Christina A.
Rouster-Stevens, Kelly
Khosroshahi, Arezou
Chandrakasan, Shanmuganathan
Prahalad, Sampath
-
Funding
Funding for this research was provided by:
Marcus Foundation Atlanta
- License Information
-
More Information
Article History
Received: 10 January 2021
Accepted: 18 May 2021
First Online: 21 June 2021
Declarations
:
: The present study was approved by the Institutional Review Board (IRB) at CHOA via waiver of informed consent (IRB number STUDY00000771).
: Not applicable.
: Dr. Rostad reports grants from BioFire, grants from Janssen, grants from Moderna, grants from Micron, grants from MedImmune, grants from PaxVax, outside the submitted work; In addition, Dr. Rostad has a patent US20180333477A1 with royalties paid to Emory University.Dr. Prahalad reports serving on a Macrophage Activation Syndrome Adjudication Committee for Novartis Pharmaceuticals. In addition, he was a consultant to Sigilon Therapeutics on immune mediated diseases. These have no bearing on the work reported herein.The remaining authors have no conflicts of interest to declare.
